Herbal granules take on a stomach condition that raises cancer risk
NCT ID NCT05209633
First seen Jul 27, 2026 · Last updated Jul 28, 2026 · Updated 1 time
Summary
This trial tests whether Dendrobii granules, a traditional Chinese herbal remedy, can improve chronic atrophic gastritis — a condition where the stomach lining thins and raises the risk of stomach cancer. Twenty adults with the condition will receive either the granules or a placebo for 18 weeks. The goal is to see if the treatment can reverse precancerous changes in the stomach lining.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Dendrobii granules (a traditional Chinese medicine preparation)
- What this could lead to
- If effective, Dendrobii granules could offer a new treatment option for chronic atrophic gastritis and potentially reduce the risk of progression to gastric cancer.
- What could go wrong
- This is a small, early-phase trial with only 20 participants, so results may not apply broadly. The treatment is based on traditional Chinese medicine and lacks large-scale evidence.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATROPHIC GASTRITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The Chinese University of Hong Kong
Hong Kong, Hong Kong
More trials for these conditions
Other studies related to the condition(s) this trial covers.